All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
99% PURITY GUARANTEE
99% PURITY GUARANTEE
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.
Preparation & Handling Notice
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
RESEARCH USE ONLY
This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.
Strength: 2 mg
CAS: 910463-68-2
Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular weight: 4113.6 g/mol
Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
Synonyms: NN9535
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
Semaglutide is a synthetic GLP-1 receptor agonist analog supplied as a high-purity lyophilized peptide for laboratory research. It is widely studied in metabolic and endocrine research models to investigate glucose regulation, hormone signaling, and receptor-mediated cellular responses under controlled experimental conditions.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1–2 business days.
-
Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.
Why Choose NOVERA COMPOUNDS Peptides?
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
- High-purity, research-grade peptide synthesis
- Analytical testing to verify quality and composition
- Consistent batch-to-batch performance
- Batch identification on every vial for traceability
- Stored and shipped under controlled conditions
High-purity, research-grade peptide synthesis
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
What is Semaglutide (2 mg)?
Semaglutide (2 mg) is a synthetic peptide commonly studied in metabolic and endocrine research. It is a modified version of glucagon-like peptide-1 (GLP-1), a natural hormone that plays a key role in regulating glucose and metabolism.
This peptide has specific amino acid substitutions and a lipid modification that enhance its stability and prolong its interaction with the GLP-1 receptor, making it more suitable for extended studies than native GLP-1, which is rapidly broken down in the body.
In research environments, Semaglutide (2 mg) is used to study hormone-receptor interactions, signaling pathways, and metabolic communication. The 2 mg dosage is ideal for small-scale in vitro studies, pilot experiments, and assay validation that require controlled amounts of peptide.
Product Specifications
- CAS Number: 910463-68-2
- Synonym: NN9535
- Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
- Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Molecular Weight: 4113.6 g/mol
- Purity: ≥95% (verified by HPLC and mass spectrometry)
- Packaging Format: 2 mg lyophilized powder in sealed research-grade vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long term). Protect from light.
- Intended Use: For Laboratory Research Use Only
Key Characteristics of Semaglutide (2 mg)
- A synthetic GLP-1 receptor agonist analog designed for experimental use
- Structurally modified for enhanced stability in research settings
- Lipid conjugation enables prolonged receptor interaction in vitro
- High analytical purity, confirmed by HPLC and mass spectrometry
- Supplied as lyophilized powder to preserve structural integrity before reconstitution
- Suitable for studies in endocrine, metabolic, and receptor signaling research
- Compatible with standard peptide handling and analytical workflows
How Semaglutide (2 mg) Supports Research
Semaglutide (2 mg) is used in laboratories to study GLP-1 receptor signaling and its role in metabolism. Researchers use this peptide to explore receptor binding, second-messenger activation (like cAMP signaling), and hormone-driven cellular responses under controlled conditions.
Due to its enhanced stability compared to native GLP-1, Semaglutide allows for the study of prolonged receptor engagement and modulation of downstream pathways. It is commonly used in cellular assays, receptor activation studies, and metabolic models to assess endocrine communication and regulatory feedback mechanisms.
Research Applications & Usage Information
Semaglutide (2 mg) is typically used in laboratory and preclinical research focused on:
- GLP-1 receptor activation and binding studies
- Incretin hormone signaling pathway analysis
- Glucose metabolism and insulin regulation studies
- Endocrine system communication research
- Cellular signaling and receptor pharmacodynamics investigations
- Comparative analysis of GLP-1 analogs in controlled experiments
All applications are for investigational use and are limited to in vitro or preclinical laboratory settings.
Handling and Storage Recommendations
- Store at 2–8 °C (≤–20 °C for long-term storage). Protect from light.
- Keep the vial sealed until ready for reconstitution.
- Minimize exposure to moisture and direct light.
- Allow the vial to equilibrate before opening to reduce condensation.
- After reconstitution, store solutions at 2–8 °C according to lab protocols.
- Avoid repeated freeze-thaw cycles to maintain peptide stability.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015;58(18):7370-7380. doi:10.1021/acs.jmedchem.5b00726
- Loomba R, Abdelmalek MF, Armstrong MJ, et al. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8(6):511-522. doi:10.1016/S2468-1253(23)00068-7
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Published 2019 Apr 12. doi:10.3389/fendo.2019.00155
What is Semaglutide (2 mg)?
Semaglutide (2 mg) is a synthetic peptide commonly studied in metabolic and endocrine research. It is a modified version of glucagon-like peptide-1 (GLP-1), a natural hormone that plays a key role in regulating glucose and metabolism.
This peptide has specific amino acid substitutions and a lipid modification that enhance its stability and prolong its interaction with the GLP-1 receptor, making it more suitable for extended studies than native GLP-1, which is rapidly broken down in the body.
In research environments, Semaglutide (2 mg) is used to study hormone-receptor interactions, signaling pathways, and metabolic communication. The 2 mg dosage is ideal for small-scale in vitro studies, pilot experiments, and assay validation that require controlled amounts of peptide.
Product Specifications
- CAS Number: 910463-68-2
- Synonym: NN9535
- Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
- Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Molecular Weight: 4113.6 g/mol
- Purity: ≥95% (verified by HPLC and mass spectrometry)
- Packaging Format: 2 mg lyophilized powder in sealed research-grade vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long term). Protect from light.
- Intended Use: For Laboratory Research Use Only
Key Characteristics of Semaglutide (2 mg)
- A synthetic GLP-1 receptor agonist analog designed for experimental use
- Structurally modified for enhanced stability in research settings
- Lipid conjugation enables prolonged receptor interaction in vitro
- High analytical purity, confirmed by HPLC and mass spectrometry
- Supplied as lyophilized powder to preserve structural integrity before reconstitution
- Suitable for studies in endocrine, metabolic, and receptor signaling research
- Compatible with standard peptide handling and analytical workflows
How Semaglutide (2 mg) Supports Research
Semaglutide (2 mg) is used in laboratories to study GLP-1 receptor signaling and its role in metabolism. Researchers use this peptide to explore receptor binding, second-messenger activation (like cAMP signaling), and hormone-driven cellular responses under controlled conditions.
Due to its enhanced stability compared to native GLP-1, Semaglutide allows for the study of prolonged receptor engagement and modulation of downstream pathways. It is commonly used in cellular assays, receptor activation studies, and metabolic models to assess endocrine communication and regulatory feedback mechanisms.
Research Applications & Usage Information
Semaglutide (2 mg) is typically used in laboratory and preclinical research focused on:
- GLP-1 receptor activation and binding studies
- Incretin hormone signaling pathway analysis
- Glucose metabolism and insulin regulation studies
- Endocrine system communication research
- Cellular signaling and receptor pharmacodynamics investigations
- Comparative analysis of GLP-1 analogs in controlled experiments
All applications are for investigational use and are limited to in vitro or preclinical laboratory settings.
Handling and Storage Recommendations
- Store at 2–8 °C (≤–20 °C for long-term storage). Protect from light.
- Keep the vial sealed until ready for reconstitution.
- Minimize exposure to moisture and direct light.
- Allow the vial to equilibrate before opening to reduce condensation.
- After reconstitution, store solutions at 2–8 °C according to lab protocols.
- Avoid repeated freeze-thaw cycles to maintain peptide stability.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015;58(18):7370-7380. doi:10.1021/acs.jmedchem.5b00726
- Loomba R, Abdelmalek MF, Armstrong MJ, et al. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8(6):511-522. doi:10.1016/S2468-1253(23)00068-7
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Published 2019 Apr 12. doi:10.3389/fendo.2019.00155
Related products
